Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The microtubule-associated protein tau favors microtubule nucleation and stabilization and plays a role in the elongation of axons. We have investigated the ability of glycogen synthase kinase-3beta (GSK-3beta) to control tau-induced processes outgrowth. Tau-transfected Chinese hamster ovary (CHO) cells developed processes containing microtubule bundles after cytochalasin treatment, but a significant reduction in the number of cells harboring processes was observed in tau/GSK-3beta-co-transfected cells. Lithium, an inhibitor of GSK-3beta, counteracted in a dose-dependent manner this inhibitory effect of GSK-3beta. These findings suggest that GSK-3beta modulates in a graded manner the ability of tau to control the microtubule-dependent induction of cell processes.

Type

Journal article

Journal

FEBS Lett

Publication Date

07/01/2000

Volume

465

Pages

34 - 38

Keywords

Animals, CHO Cells, Calcium-Calmodulin-Dependent Protein Kinases, Cell Cycle, Cricetinae, Cytochalasin B, Enzyme Inhibitors, Glycogen Synthase Kinase 3, Glycogen Synthase Kinases, Immunoblotting, Lithium, Phosphorylation, Transfection, tau Proteins